Celltrion
068270.KS
$140.59
Share price
0.05%
Change (1 day)
11.86%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Cash on Hand
Cash on Hand as of December 2023 : $0.58 B
According to Celltrion
's latest financial reports the company has $0.58 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Celltrion - Cash on Hand chart (from 2007 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.47 B | -54.01% |
| 2021-12-31 | $1.02 B | 59.5% |
| 2020-12-31 | $0.64 B | 18.39% |
| 2019-12-31 | $0.54 B | 13.88% |
| 2018-12-31 | $0.47 B | -8.91% |
| 2017-12-31 | $0.52 B | 130.1% |
| 2016-12-31 | $0.22 B | 71.46% |
| 2015-12-31 | $0.13 B | 22.61% |
| 2014-12-31 | $0.10 B | 0.82% |
| 2013-12-31 | $0.10 B | 7.97% |
| 2012-12-31 | $99.38 M | 96.5% |
| 2011-12-31 | $50.57 M | -53.65% |
| 2010-12-31 | $0.10 B | 471.53% |
| 2009-12-31 | $19.09 M | 465.7% |
| 2008-12-31 | $3.37 M | -25.94% |
| 2007-12-31 | $4.55 M |